These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397 [TBL] [Abstract][Full Text] [Related]
4. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies. Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641 [TBL] [Abstract][Full Text] [Related]
6. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination. Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147 [TBL] [Abstract][Full Text] [Related]
7. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland. Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT; J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281 [TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Martinelli M; Musumeci R; Rizzo A; Muresu N; Piana A; Sotgiu G; Landoni F; Cocuzza C Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514378 [No Abstract] [Full Text] [Related]
10. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China. Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906 [TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078 [TBL] [Abstract][Full Text] [Related]
13. Variants of human papillomavirus types 16 and 18: histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear. Rabelo-Santos SH; Villa LL; Derchain SF; Ferreira S; Sarian LO; Angelo-Andrade LA; do Amaral Westin MC; Zeferino LC Int J Gynecol Pathol; 2006 Oct; 25(4):393-7. PubMed ID: 16990718 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. Kwaśniewska A; Korobowicz E; Zdunek M; Skoczyński M; Kwaśniewski W; Daniłoś J; Goździcka-Józefiak A Eur J Gynaecol Oncol; 2009; 30(1):65-70. PubMed ID: 19317260 [TBL] [Abstract][Full Text] [Related]
16. Chlamydia Trachomatis Infection in High-Risk Human Papillomavirus Based on Cervical Cytology Specimen. Sangpichai S; Patarapadungkit N; Pientong C; Ekalaksananan T; Chaiwiriyakul S; Thongbor R; Sirivech P; Jangsiriwitayakorn P; Triamwittayanon T Asian Pac J Cancer Prev; 2019 Dec; 20(12):3843-3847. PubMed ID: 31870131 [TBL] [Abstract][Full Text] [Related]
17. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Finan RR; Tamim H; Almawi WY Arch Gynecol Obstet; 2002 Jul; 266(3):168-71. PubMed ID: 12197559 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HPV physical status and integration sites in cervical cancer. Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172 [TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type distribution in cervical cancer in Delhi, India. Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]